Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus. - Wikidata - wikimedia - TriplyDB

Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus.

Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus.

http://www.wikidata.org/entity/Q41757581

about

Noninvasive Measures of Liver Fibrosis and Severity of Liver Disease.Effects of storage conditions on the stability of serum CD163, NGAL, HMGB1 and MIP2 Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets.The macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients.The soluble mannose receptor is released from the liver in cirrhotic patients, but is not associated with bacterial translocation.Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation.Presepsin: A potential biomarker of PJI? A comparative analysis with known and new infection biomarkers.No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial

P2860

Q30381236-C40F9358-2115-4396-8600-956A988D0F15 Q35741156-E6AFEAA3-1C7B-4B36-8A44-633892AD04F7 Q36947366-2D4B3240-770B-407D-9C42-E01CA0265AE9 Q40337789-2C0642C5-FB81-4F0D-89D0-FA9C51D45A7D Q40495697-AA3A8C4F-236D-4621-96A7-6797357BFBC5 Q47266129-5D5835FA-BC61-478E-8FB7-E6BAC8A36AD8 Q47282539-067DCAA8-C453-496B-978F-3C2F2018D2E6 Q58763693-B54A6CC4-9C47-4221-8BFE-31A8888A6CF7

P2860

Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus.

http://www.wikidata.org/entity/Q41757581

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Soluble CD163 is an indicator ...... ed with the hepatitis B virus.

@en

type

label

Soluble CD163 is an indicator ...... ed with the hepatitis B virus.

@en

prefLabel

Soluble CD163 is an indicator ...... ed with the hepatitis B virus.

@en

P1433

Q41757581-98C75FFF-8902-4878-A3F2-2990E13035E7

P1476

Q41757581-7E88BB6F-F96A-4764-91E3-DBC5806D83BF

P2093

Q41757581-06769F59-4DEE-412A-9B6F-BCA0E8B115AB

Q41757581-23683D28-91C9-47C1-88BC-057B59B40F39

Q41757581-2A759948-ED9D-409B-B0AD-0FCB47945F99

Q41757581-545EE944-FC7D-4A5C-9A9A-FBFA70EB875D

Q41757581-9978EDD0-F295-458E-8706-902EBAFA9F96

Q41757581-A1F0EC76-318C-4B5A-91EB-8FE666E36149

Q41757581-A9C99B35-21C2-4433-8662-07F9928A07C3

Q41757581-AE123FB9-38A1-48F2-9FCC-9B80A0E63490

Q41757581-D2CFCB7F-AA5E-4699-89D8-9962CE8B4B9B

Q41757581-E17F5839-C98C-47F6-8B8C-DB5C5936C664

P2860

Q41757581-24BDFCAB-E7DD-440B-A5B6-0F5E602D78E4

Q41757581-250DC129-AF0F-4849-A464-06C21DFE4610

Q41757581-2805E79E-FD14-4B41-9581-350B2C60A96E

Q41757581-28DC819C-9F25-40F9-A7AE-1F9F6A9E5107

Q41757581-2DB3EC0E-D4FD-4E6E-B984-7017D83DFF46

Q41757581-359E6ED5-20D6-487A-92C5-6F91DF4AF131

Q41757581-3D229C01-AF3B-4DF4-9495-33F1227B6772

Q41757581-425E76B7-9DBE-4364-889B-4FB627E365E3

Q41757581-45F141A0-6A5E-4965-A0D5-DABC62B0ACF9

Q41757581-48F5BC37-D807-42EF-A1C5-50D9F824168D

P304

Q41757581-26A0E150-438E-4AE5-BDAE-02E23189269A

P31

Q41757581-93D7B7D3-CC67-4354-BDA2-A566196E27DE

P356

Q41757581-48FD1F70-8255-488D-8945-9A962A9D3C88

P433

Q41757581-EC88EF53-CCF2-46AE-97C1-8B98E18FE508

P478

Q41757581-475808D1-F723-4A48-A90F-7F0B0A4C3F0D

P577

Q41757581-5361DB03-A87D-47FB-BADE-CB8093985D8F

P698

Q41757581-659F405B-ADFC-4CAE-8929-F0E5E02F5EDB

P356

P1433

Journal of Viral Hepatitis

P1476

Soluble CD163 is an indicator ...... ed with the hepatitis B virus.

@en

P2093

A Berger

http://www.w3.org/2001/XMLSchema#string

A Piiper

http://www.w3.org/2001/XMLSchema#string

B Kronenberger

http://www.w3.org/2001/XMLSchema#string

G Dultz

http://www.w3.org/2001/XMLSchema#string

H Farnik

http://www.w3.org/2001/XMLSchema#string

J Vermehren

http://www.w3.org/2001/XMLSchema#string

L Gerber

http://www.w3.org/2001/XMLSchema#string

O Waidmann

http://www.w3.org/2001/XMLSchema#string

S Zeuzem

http://www.w3.org/2001/XMLSchema#string

T Pleli

http://www.w3.org/2001/XMLSchema#string

P2860

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

Hepatitis B virus infection--natural history and clinical consequences

Histological grading and staging of chronic hepatitis

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.

Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.

Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity

Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.

Soluble CD163 from activated macrophages predicts mortality in acute liver failure.

P304

427-432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JVH.12309

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25181653

http://www.w3.org/2001/XMLSchema#string